MiNK Therapeutics

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

MiNK Therapeutics

Jul 8, 2024, 12:29 | Drugs

Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development

Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics, shared on X: “NCI Announces…

May 17, 2024, 04:19 | Blog

MiNK Therapeutics' Q1 report

MiNK Therapeutics shared on LinkedIn: . "This quarter we made significant strides across our iNKT…

Apr 5, 2024, 09:43 | Blog

Jennifer Buell: I’m matching all gifts from tonight through the end of April 5th.

Jennifer Buell, the President and Chief Executive Officer of MiNK Therapeutics, shared on Facebook: "Let’s…

Mar 24, 2024, 13:10 | Blog

MiNK Therapeutics announced results for the fourth quarter and year-end of 2023

MiNK Therapeutics shared on their LinkedIn page: "Today MiNK announced results for the fourth quarter…

Mar 7, 2024, 01:57 | Blog

Jennifer Buell: Tune-in: MiNK Therapeutics to unveil pioneering data on the novel armored FAP-CAR-INKT (MiNK-215) at AACR Meeting, April 8

Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared a post by MiNK Therapeutics…

Feb 14, 2024, 14:59 | Blog

Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL

Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…

Feb 6, 2024, 14:34 | Blog

Potential of iNKT cells to combat resistance to immune checkpoint inhibitors - MiNK Therapeutics

Quoting MiNK Therapeutics on LinkedIn: "New publication in Oncogene spotlights a compelling case study of…

Oct 3, 2023, 16:52 | Blog,Insight

Jennifer Buell: MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023 - Bloomberg.

Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared a post by Bloomberg…

All: 8 Posts: 1 - 100